{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:45:09Z","timestamp":1791409509036,"version":"4.3.3"},"reference-count":81,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,9,1]]},"abstract":"<jats:sec>\n                  <jats:title>BACKGROUND<\/jats:title>\n                  <jats:p>During their biological life, proteins are exposed in a cumulative fashion to irreversible nonenzymatic, late posttranslational modifications that are responsible for their molecular aging. It is now well established that these damaged proteins constitute a molecular substratum for many dysfunctions described in metabolic and age-related diseases, such as diabetes mellitus, renal insufficiency, atherosclerosis, or neurodegenerative diseases. Accordingly, the specific end products derived from these reactions are considered potentially useful biomarkers for these diseases.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONTENT<\/jats:title>\n                  <jats:p>The aim of this review is to give an overview of nonenzymatic posttranslational modifications of proteins and their influence in vivo, take inventory of the analytical methods available for the measurement of posttranslational modification\u2013derived products, and assess the potential contribution of new technologies for their clinical use as biological markers of protein molecular aging.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>SUMMARY<\/jats:title>\n                  <jats:p>Despite their clinical relevance, biomarkers of posttranslational modifications of proteins have been studied only in the context of experimental clinical research, owing to the analytical complexity of their measurement. The recent implementation in clinical chemistry laboratories of mass spectrometry\u2013based methods that provide higher specificity and sensitivity has facilitated the measurement of these compounds. These markers are not used currently by clinicians in routine practice, however, and many challenges, such as standardization, have to be confronted before these markers can be used as efficient tools in the detection and monitoring of long-term complications of metabolic and age-related diseases.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1373\/clinchem.2010.145201","type":"journal-article","created":{"date-parts":[[2010,6,21]],"date-time":"2010-06-21T00:17:57Z","timestamp":1277079477000},"page":"1401-1412","source":"Crossref","is-referenced-by-count":122,"title":["Evaluation of Nonenzymatic Posttranslational Modification\u2013Derived Products as Biomarkers of Molecular Aging of Proteins"],"prefix":"10.1093","volume":"56","author":[{"given":"St\u00e9phane","family":"Jaisson","sequence":"first","affiliation":[{"name":"Laboratory of Paediatric Biology and Research, American Memorial Hospital, University Hospital of Reims and Laboratory of Biochemistry and Molecular Biology, UMR CNRS\/URCA no. 6237, Faculty of Medicine, Reims, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Gillery","sequence":"first","affiliation":[{"name":"Laboratory of Paediatric Biology and Research, American Memorial Hospital, University Hospital of Reims and Laboratory of Biochemistry and Molecular Biology, UMR CNRS\/URCA no. 6237, Faculty of Medicine, Reims, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2010,9,1]]},"reference":[{"key":"2020022704325187300_B1","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.exger.2007.12.001","article-title":"Nonenzymatic posttranslational protein modifications in ageing","volume":"43","author":"Soskic","year":"2008","journal-title":"Exp Gerontol"},{"key":"2020022704325187300_B2","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1373\/clinchem.2004.034645","article-title":"The clinical chemome: a tool for the diagnosis and management of chronic disease","volume":"50","author":"Baynes","year":"2004","journal-title":"Clin Chem"},{"key":"2020022704325187300_B3","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1475-2840-7-29","article-title":"The clinical relevance of assessing advanced glycation endproducts accumulation in diabetes","volume":"7","author":"Meerwaldt","year":"2008","journal-title":"Cardiovasc Diabetol"},{"key":"2020022704325187300_B4","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s001250051591","article-title":"Advanced glycation end-products: a review","volume":"44","author":"Singh","year":"2001","journal-title":"Diabetologia"},{"key":"2020022704325187300_B5","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1006\/bbrc.1996.1695","article-title":"Rapid formation of advanced glycation end products by intermediate metabolites of glycolytic pathway and polyol pathway","volume":"228","author":"Hamada","year":"1996","journal-title":"Biochem Biophys Res Commun"},{"key":"2020022704325187300_B6","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1463-1326.2006.00595.x","article-title":"Advanced glycation endproducts: what is their relevance to diabetic complications?","volume":"9","author":"Ahmed","year":"2007","journal-title":"Diabetes Obes Metab"},{"key":"2020022704325187300_B7","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/ndt\/14.suppl_1.76","article-title":"Advanced oxidation protein products as a novel molecular basis of oxidative stress in uraemia","volume":"14","author":"Witko-Sarsat","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"2020022704325187300_B8","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1007\/s00125-005-1810-7","article-title":"Degradation products of proteins damaged by glycation, oxidation and nitration in clinical type 1 diabetes","volume":"48","author":"Ahmed","year":"2005","journal-title":"Diabetologia"},{"key":"2020022704325187300_B9","doi-asserted-by":"crossref","first-page":"21837","DOI":"10.1074\/jbc.R700019200","article-title":"Oxidative stress and covalent modification of protein with bioactive aldehydes","volume":"283","author":"Grimsrud","year":"2008","journal-title":"J Biol Chem"},{"key":"2020022704325187300_B10","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1055\/s-2002-32041","article-title":"Glycation, carbonyl stress, EAGLEs, and the vascular complications of diabetes","volume":"2","author":"Lyons","year":"2002","journal-title":"Semin Vasc Med"},{"key":"2020022704325187300_B11","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/sj.bjp.0707395","article-title":"Advanced lipid peroxidation end products in oxidative damage to proteins: potential role in diseases and therapeutic prospects for the inhibitors","volume":"153","author":"Negre-Salvayre","year":"2008","journal-title":"Br J Pharmacol"},{"key":"2020022704325187300_B12","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.1046\/j.1523-1755.2001.59780102.x","article-title":"Carbamoylation of amino acids and proteins in uremia","volume":"78","author":"Kraus","year":"2001","journal-title":"Kidney Int Suppl"},{"key":"2020022704325187300_B13","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/nm1637","article-title":"Protein carbamylation links inflammation, smoking, uremia and atherogenesis","volume":"13","author":"Wang","year":"2007","journal-title":"Nat Med"},{"key":"2020022704325187300_B14","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.clinbiochem.2006.07.009","article-title":"Biochemistry of amino acid racemization and clinical application to musculoskeletal disease","volume":"39","author":"McCudden","year":"2006","journal-title":"Clin Biochem"},{"key":"2020022704325187300_B15","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.atherosclerosis.2007.07.025","article-title":"Receptor for advanced glycation endproducts and atherosclerosis: from basic mechanisms to clinical implications","volume":"196","author":"Basta","year":"2008","journal-title":"Atherosclerosis"},{"key":"2020022704325187300_B16","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1515\/CCLM.2003.179","article-title":"Chem modification of proteins by lipids in diabetes","volume":"41","author":"Baynes","year":"2003","journal-title":"Clin Chem Lab Med"},{"key":"2020022704325187300_B17","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00726-007-0606-0","article-title":"Advanced glycation end-products (AGEs): involvement in aging and in neurodegenerative diseases","volume":"35","author":"Grillo","year":"2008","journal-title":"Amino Acids"},{"key":"2020022704325187300_B18","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S1568-1637(02)00012-0","article-title":"Viewing molecular mechanisms of ageing through a lens","volume":"1","author":"Harding","year":"2002","journal-title":"Ageing Res Rev"},{"key":"2020022704325187300_B19","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.cca.2006.03.017","article-title":"Glycation endproducts in osteoporosis: is there a pathophysiologic importance?","volume":"371","author":"Hein","year":"2006","journal-title":"Clin Chim Acta"},{"key":"2020022704325187300_B20","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s12272-009-1802-0","article-title":"Role of protein tyrosine nitration in neurodegenerative diseases and atherosclerosis","volume":"32","author":"Lee","year":"2009","journal-title":"Arch Pharm Res"},{"key":"2020022704325187300_B21","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1161\/01.ATV.0000214960.85469.68","article-title":"Advanced oxidation protein products accelerate atherosclerosis through promoting oxidative stress and inflammation","volume":"26","author":"Liu","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2020022704325187300_B22","doi-asserted-by":"crossref","first-page":"763","DOI":"10.3233\/JAD-2009-1013","article-title":"Oxidative stress in diabetes and Alzheimer's disease","volume":"16","author":"Reddy","year":"2009","journal-title":"J Alzheimers Dis"},{"key":"2020022704325187300_B23","doi-asserted-by":"crossref","first-page":"845","DOI":"10.3233\/JAD-2009-0974","article-title":"Involvement of toxic AGEs (TAGE) in the pathogenesis of diabetic vascular complications and Alzheimer's disease","volume":"16","author":"Takeuchi","year":"2009","journal-title":"J Alzheimers Dis"},{"key":"2020022704325187300_B24","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1053\/j.jrn.2006.04.012","article-title":"Advanced glycation end products in renal failure","volume":"16","author":"Thornalley","year":"2006","journal-title":"J Ren Nutr"},{"key":"2020022704325187300_B25","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0014-5793(04)00233-9","article-title":"Enhanced activation of and increased production of matrix metalloproteinase-9 by human blood monocytes upon adhering to carbamylated collagen","volume":"563","author":"Garnotel","year":"2004","journal-title":"FEBS Lett"},{"key":"2020022704325187300_B26","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.chembiol.2005.11.005","article-title":"Impact of carbamylation on type I collagen conformational structure and its ability to activate human polymorphonuclear neutrophils","volume":"13","author":"Jaisson","year":"2006","journal-title":"Chem Biol"},{"key":"2020022704325187300_B27","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.2337\/diabetes.54.10.2952","article-title":"Mechanism of perturbation of integrin-mediated cell-matrix interactions by reactive carbonyl compounds and its implication for pathogenesis of diabetic nephropathy","volume":"54","author":"Pedchenko","year":"2005","journal-title":"Diabetes"},{"key":"2020022704325187300_B28","first-page":"25","article-title":"Glycation of proteins as a source of superoxide","volume":"14","author":"Gillery","year":"1988","journal-title":"Diabete Metab"},{"key":"2020022704325187300_B29","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.2337\/diabetes.48.9.1842","article-title":"Autoantibody against N(epsilon)-(carboxymethyl)lysine: an advanced glycation end product of the Maillard reaction","volume":"48","author":"Shibayama","year":"1999","journal-title":"Diabetes"},{"key":"2020022704325187300_B30","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1161\/CIRCULATIONAHA.106.621854","article-title":"Advanced glycation end products: sparking the development of diabetic vascular injury","volume":"114","author":"Goldin","year":"2006","journal-title":"Circulation"},{"key":"2020022704325187300_B31","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/mnfr.200700101","article-title":"N(epsilon)-carboxymethyllysine-modified proteins are unable to bind to RAGE and activate an inflammatory response","volume":"52","author":"Buetler","year":"2008","journal-title":"Mol Nutr Food Res"},{"key":"2020022704325187300_B32","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ab.2003.09.013","article-title":"Advanced glycation end product ligands for the receptor for advanced glycation end products: biochemical characterization and formation kinetics","volume":"324","author":"Valencia","year":"2004","journal-title":"Anal Biochem"},{"key":"2020022704325187300_B33","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1002\/mnfr.200700017","article-title":"Dietary AGEs and ALEs and risk to human health by their interaction with the receptor for advanced glycation endproducts (RAGE): an introduction","volume":"51","author":"Thornalley","year":"2007","journal-title":"Mol Nutr Food Res"},{"key":"2020022704325187300_B34","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1161\/01.RES.0000137876.28454.64","article-title":"Protein glycation: a firm link to endothelial cell dysfunction","volume":"95","author":"Wautier","year":"2004","journal-title":"Circ Res"},{"key":"2020022704325187300_B35","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3109\/10799899909036650","article-title":"Binding of long-term glycated low density lipoprotein and AGE-albumin by peripheral monocytes and endothelial cells","volume":"19","author":"Sobal","year":"1999","journal-title":"J Recept Signal Transduct Res"},{"key":"2020022704325187300_B36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2005.08.008","article-title":"Structural modifications of HDL and functional consequences","volume":"184","author":"Ferretti","year":"2006","journal-title":"Atherosclerosis"},{"key":"2020022704325187300_B37","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1515\/CCLM.2003.183","article-title":"Glycated hemoglobin standardization: National Glycohemoglobin Standardization Program (NGSP) perspective","volume":"41","author":"Little","year":"2003","journal-title":"Clin Chem Lab Med"},{"key":"2020022704325187300_B38","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2337\/diacare.21.2.265","article-title":"Evaluation of GHb assays in France by national quality control surveys","volume":"21","author":"Gillery","year":"1998","journal-title":"Diabetes Care"},{"key":"2020022704325187300_B39","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0378-4347(97)00245-4","article-title":"Chromatographic and electrophoretic methods for modified hemoglobins","volume":"699","author":"Frantzen","year":"1997","journal-title":"J Chromatogr B Biomed Sci Appl"},{"key":"2020022704325187300_B40","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2337\/diab.33.1.73","article-title":"Quantitation of glycosylated hemoglobin by boronate affinity chromatography","volume":"33","author":"Fluckiger","year":"1984","journal-title":"Diabetes"},{"key":"2020022704325187300_B41","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1093\/clinchem\/43.5.771","article-title":"Potential of electrospray mass spectrometry for quantifying glycohemoglobin","volume":"43","author":"Roberts","year":"1997","journal-title":"Clin Chem"},{"key":"2020022704325187300_B42","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1515\/CCLM.2002.016","article-title":"Approved IFCC reference method for the measurement of HbA1c in human blood","volume":"40","author":"Jeppsson","year":"2002","journal-title":"Clin Chem Lab Med"},{"key":"2020022704325187300_B43","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.2337\/dc07-9925","article-title":"Consensus statement on the worldwide standardization of the hemoglobin A1C measurement: the American Diabetes Association, European Association for the Study of Diabetes, International Federation of Clinical Chemistry and Laboratory Medicine, and the International Diabetes Federation","volume":"30","year":"2007","journal-title":"Diabetes Care"},{"key":"2020022704325187300_B44","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0009-8981(83)90078-5","article-title":"Fructosamine: a new approach to the estimation of serum glycosylprotein","volume":"127","author":"Johnson","year":"1983","journal-title":"An index of diabetic control. Clin Chim Acta"},{"key":"2020022704325187300_B45","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/0378-4347(95)00038-K","article-title":"Reliable determination of furosine in human serum and dialysate proteins by high-performance liquid chromatography","volume":"667","author":"Wu","year":"1995","journal-title":"J Chromatogr B Biomed Appl"},{"key":"2020022704325187300_B46","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.metabol.2005.02.017","article-title":"A novel advanced glycation index and its association with diabetes and microangiopathy","volume":"54","author":"Sampathkumar","year":"2005","journal-title":"Metabolism"},{"key":"2020022704325187300_B47","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s00125-009-1308-9","article-title":"Skin autofluorescence provides additional information to the UK Prospective Diabetes Study (UKPDS) risk score for the estimation of cardiovascular prognosis in type 2 diabetes mellitus","volume":"52","author":"Lutgers","year":"2009","journal-title":"Diabetologia"},{"key":"2020022704325187300_B48","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.jchromb.2009.01.022","article-title":"Measurement of pentosidine in human plasma protein by a single-column high-performance liquid chromatography method with fluorescence detection","volume":"877","author":"Scheijen","year":"2009","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"2020022704325187300_B49","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1042\/bj3640015","article-title":"Chromatographic assay of glycation adducts in human serum albumin glycated in vitro by derivatization with 6-aminoquinolyl-N-hydroxysuccinimidyl-carbamate and intrinsic fluorescence","volume":"364","author":"Ahmed","year":"2002","journal-title":"Biochem J"},{"key":"2020022704325187300_B50","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1515\/CCLM.2005.089","article-title":"Two immunochemical assays to measure advanced glycation end-products in serum from dialysis patients","volume":"43","author":"Zhang","year":"2005","journal-title":"Clin Chem Lab Med"},{"key":"2020022704325187300_B51","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/bmc.491","article-title":"Rapid and simple method for determination of Nepsilon-(carboxymethyl)lysine and Nepsilon-(carboxyethyl)lysine in urine using gas chromatography\/mass spectrometry","volume":"19","author":"Petrovic","year":"2005","journal-title":"Biomed Chromatogr"},{"key":"2020022704325187300_B52","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1042\/bj20030763","article-title":"Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry","volume":"375","author":"Thornalley","year":"2003","journal-title":"Biochem J"},{"key":"2020022704325187300_B53","doi-asserted-by":"crossref","first-page":"12310","DOI":"10.1074\/jbc.M500733200","article-title":"Glucosepane is a major protein cross-link of the senescent human extracellular matrix: relationship with diabetes","volume":"280","author":"Sell","year":"2005","journal-title":"J Biol Chem"},{"key":"2020022704325187300_B54","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1042\/bj3220317","article-title":"Quantification of malondialdehyde and 4-hydroxynonenal adducts to lysine residues in native and oxidized human low-density lipoprotein","volume":"322","author":"Requena","year":"1997","journal-title":"Biochem J"},{"key":"2020022704325187300_B55","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1515\/CCLM.2005.050","article-title":"Advanced oxidation protein products (AOPP) for monitoring oxidative stress in critically ill patients: a simple, fast and inexpensive automated technique","volume":"43","author":"Selmeci","year":"2005","journal-title":"Clin Chem Lab Med"},{"key":"2020022704325187300_B56","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0076-6879(99)00121-4","article-title":"Detecting oxidative modification of biomolecules with isotope dilution mass spectrometry: sensitive and quantitative assays for oxidized amino acids in proteins and tissues","volume":"300","author":"Heinecke","year":"1999","journal-title":"Methods Enzymol"},{"key":"2020022704325187300_B57","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0003-2697(02)00537-7","article-title":"Simultaneous determination of methionine sulfoxide and methionine in blood plasma using gas chromatography-mass spectrometry","volume":"313","author":"Mashima","year":"2003","journal-title":"Anal Biochem"},{"key":"2020022704325187300_B58","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3164\/jcbn.08-185","article-title":"Quantification of modified tyrosines in healthy and diabetic human urine using liquid chromatography\/tandem mass spectrometry","volume":"44","author":"Kato","year":"2009","journal-title":"J Clin Biochem Nutr"},{"key":"2020022704325187300_B59","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/clinchem\/36.4.607","article-title":"Determination of carbamylated hemoglobin by high-performance liquid chromatography","volume":"36","author":"Kwan","year":"1990","journal-title":"Clin Chem"},{"key":"2020022704325187300_B60","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1159\/000058397","article-title":"Carbamylated hemoglobin as a therapeutic marker in hemodialysis","volume":"91","author":"Hasuike","year":"2002","journal-title":"Nephron"},{"key":"2020022704325187300_B61","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1515\/CCLM.2009.136","article-title":"Carbamylated hemoglobin remains a critical issue in HbA1c measurements","volume":"47","author":"Szymezak","year":"2009","journal-title":"Clin Chem Lab Med"},{"key":"2020022704325187300_B62","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1046\/j.1523-1755.1998.00777.x","article-title":"Carbamylated hemoglobin and carbamylated plasma protein in hemodialyzed patients","volume":"53","author":"Balion","year":"1998","journal-title":"Kidney Int"},{"key":"2020022704325187300_B63","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.clinbiochem.2006.03.012","article-title":"A novel HPLC method for the measurement of thiobarbituric acid reactive substances (TBARS): a comparison with a commercially available kit","volume":"39","author":"Seljeskog","year":"2006","journal-title":"Clin Biochem"},{"key":"2020022704325187300_B64","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1515\/CCLM.2003.180","article-title":"Glyoxal and methylglyoxal levels in diabetic patients: quantitative determination by a new GC\/MS method","volume":"41","author":"Lapolla","year":"2003","journal-title":"Clin Chem Lab Med"},{"key":"2020022704325187300_B65","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jpba.2006.01.047","article-title":"Analytical methods for trace levels of reactive carbonyl compounds formed in lipid peroxidation systems","volume":"41","author":"Shibamoto","year":"2006","journal-title":"J Pharm Biomed Anal"},{"key":"2020022704325187300_B66","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1006\/abbi.1997.0117","article-title":"Quantitation of 3-deoxyglucosone levels in human plasma","volume":"342","author":"Lal","year":"1997","journal-title":"Arch Biochem Biophys"},{"key":"2020022704325187300_B67","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.bbrc.2004.10.131","article-title":"Immunochemical detection of 3-deoxyglucosone in serum","volume":"325","author":"Uchida","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"2020022704325187300_B68","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0003-2697(85)90572-X","article-title":"A spectrophotometric determination of cyanate using reaction with 2-aminobenzoic acid","volume":"149","author":"Guilloton","year":"1985","journal-title":"Anal Biochem"},{"key":"2020022704325187300_B69","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1006\/abio.1993.1226","article-title":"Fluorometric determination of cyanate in plasma by conversion to 2,4(1H,3H)-quinazolinedione and separation by high-performance liquid chromatography","volume":"211","author":"Lundquist","year":"1993","journal-title":"Anal Biochem"},{"key":"2020022704325187300_B70","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0022-1759(89)90275-5","article-title":"Measurement of plasma glycoalbumin levels with a monoclonal antibody based ELISA","volume":"122","author":"Cohen","year":"1989","journal-title":"J Immunol Methods"},{"key":"2020022704325187300_B71","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0009-9120(97)00026-X","article-title":"Evaluation of serum glycated lipoprotein(a) levels in noninsulin-dependent diabetic patients","volume":"30","author":"Klaya","year":"1997","journal-title":"Clin Biochem"},{"issue":"Pt 4","key":"2020022704325187300_B72","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1177\/000456320003700411","article-title":"Glycated apolipoprotein A-I assay by combination of affinity chromatography and latex immunoagglutination","volume":"37","author":"Shishino","year":"2000","journal-title":"Ann Clin Biochem"},{"key":"2020022704325187300_B73","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1373\/clinchem.2004.044032","article-title":"Quantification of carbamylated LDL in human sera by a new sandwich ELISA","volume":"51","author":"Apostolov","year":"2005","journal-title":"Clin Chem"},{"key":"2020022704325187300_B74","first-page":"275","article-title":"Differences in the results and interpretation of oxidized LDL cholesterol by two ELISA assays: an evaluation with samples from the PIOstat study","volume":"55","author":"Pfutzner","year":"2009","journal-title":"Clin Lab"},{"key":"2020022704325187300_B75","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.2337\/diacare.28.10.2465","article-title":"Glycated and oxidized protein degradation products are indicators of fasting and postprandial hyperglycemia in diabetes","volume":"28","author":"Ahmed","year":"2005","journal-title":"Diabetes Care"},{"key":"2020022704325187300_B76","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.2337\/diabetes.49.10.1627","article-title":"Identification, cloning, and heterologous expression of a mammalian fructosamine-3-kinase","volume":"49","author":"Delpierre","year":"2000","journal-title":"Diabetes"},{"key":"2020022704325187300_B77","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.mrfmmm.2005.03.024","article-title":"Advanced glycoxidation end products in chronic diseases: clinical chemistry and genetic background","volume":"579","author":"Kalousova","year":"2005","journal-title":"Mutat Res"},{"key":"2020022704325187300_B78","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/mas.20187","article-title":"Strategies for proteomic analysis of non-enzymatically glycated proteins","volume":"28","author":"Priego Capote","year":"2009","journal-title":"Mass Spectrom Rev"},{"key":"2020022704325187300_B79","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1093\/clinchem\/47.4.730","article-title":"Plasma protein contents determined by Fourier-transform infrared spectrometry","volume":"47","author":"Petibois","year":"2001","journal-title":"Clin Chem"},{"key":"2020022704325187300_B80","doi-asserted-by":"crossref","first-page":"3542","DOI":"10.1096\/fj.06-7896com","article-title":"Confocal Raman microscopy can quantify advanced glycation end product (AGE) modifications in Bruch's membrane leading to accurate, nondestructive prediction of ocular aging","volume":"21","author":"Glenn","year":"2007","journal-title":"FASEB J"},{"key":"2020022704325187300_B81","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1210\/jc.2008-1824","article-title":"Clinical review 2: The \u201cmetabolic memory\u201d: is more than just tight glucose control necessary to prevent diabetic complications?","volume":"94","author":"Ceriello","year":"2009","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Clinical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/clinchem\/article-pdf\/56\/9\/1401\/32652871\/clinchem1401.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/clinchem\/article-pdf\/56\/9\/1401\/32652871\/clinchem1401.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,27]],"date-time":"2020-02-27T09:33:48Z","timestamp":1582796028000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/clinchem\/article\/56\/9\/1401\/5622201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,1]]},"references-count":81,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2010,9,1]]},"published-print":{"date-parts":[[2010,9,1]]}},"URL":"https:\/\/doi.org\/10.1373\/clinchem.2010.145201","relation":{},"ISSN":["0009-9147","1530-8561"],"issn-type":[{"value":"0009-9147","type":"print"},{"value":"1530-8561","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2010,9,1]]},"published":{"date-parts":[[2010,9,1]]}}}